Endothelial cells (ECs) are activated in response to high-fl ow. Our previous studies using arteriovenous fi stula (AVF) model have demonstrated that high-fl ow in blood vessels induces an early and rapid proliferation of ECs before arterial dilatation. Here, we investigated the proliferation of ECs, which had once been stimulated by high-fl ow loading, in a situation without the infl uence of high-fl ow. First, we induced high-fl ow in the rabbit common carotid artery by using AVF. Then, we removed the infl uence of high-fl ow by normalization of high-fl ow with the closure of AVF or by removal of fl ow itself with tissue isolation and organ culture or with cell culture of ECs, at the timing considered that ECs began to proliferate. Kinetics of ECs was investigated by a laser scanning confocal microscopy, phase-contrast microscopy and light microscopy using bromodeoxyuridine labeling method. We found that ECs, which had once been stimulated by high-flow, transiently proliferated even after normalization of high-fl ow or removal of fl ow. We assume that proliferation of ECs is promised when these cells start to proliferate after high-fl ow loading.
Arteries are remodeled in response to a change of blood fl ow or wall shear stress (2, 5) . Endothelial cells (ECs) are considered to detect the wall shear stress on the surface of themselves and play an important role in arterial remodeling (4) . Our previous studies have demonstrated that high-flow induces the proliferation of arterial ECs before arterial dilatation in dogs, rats and rabbits by using arterio-venous fistula (AVF) model (5-9, 11, 12) . This proliferation of ECs is the most distinct and earliest morphological change (5, 9) , and is an initial change of the remodeling. However, mechanisms of the proliferation are still uncertain. In our high-flow model performed so far (5, 9) , high-fl ow was continuing during the whole experimental period. Therefore, it is not certain whether continuous highflow is necessary during the whole period of the proliferation of ECs or only transient high-fl ow is required at the beginning of the proliferation of ECs. The purpose of this study is to investigate the proliferation of ECs, which have once been stimulated by high-fl ow loading, in a situation without the infl uence of high-fl ow. Here, we removed the infl uence of high-fl ow by 1) normalization of highflow with AVF closure, 2) removal of flow with isolation and organ culture of the artery or 3) with in vitro culture of ECs immediately after the timing considered that ECs began to proliferate. Kinetics of ECs was investigated by bromodeoxyuridine (BrdU) labeling (1, 5, (8) (9) (10) . We found that ECs once been stimulated by high-fl ow proliferated even after nor-muscular) and ketamine (25 mg/kg, intramuscular) and anesthetized with inhalation anesthesia of sevoflurane (1.5% in O 2 /N 2 O, 2/1 vol/vol). To induce high-fl ow, AVF was created between the left CCA and corresponding jugular vein with sterile techniques, following the procedures by Masuda et al. (5) . Mean blood fl ow of the left CCA was measured by using an electromagnetic fl ow meter (Nihon Kohden Co., Tokyo, Japan) at 0.5 to 1.0 cm proximal to the thyroid artery branch before and after AVF and the increase of mean blood fl ow was confi rmed. Animals without an AVF operation were used as control (n = 4).
BrdU administration
To label cells in synthesis phase (S-phase) of mitotic cycle, BrdU (50 mg/kg) dissolved in physiological saline solution was administrated by intraperitoneal injection at 1 h before fi nishing 1.5 days of AVF (1, 5, 8, 9, 10) in 15 animals. Because BrdU remains in blood fl ow only for about 10 min (3), this BrdU label method is regarded as pulse-labeling. Once BrdU is incorporated in DNA, it is kept remaining. Therefore it is considered that we can track BrdUlabeled ECs, which have once been in S-phase at malization or removal of high-fl ow.
MATERIALS AND METHODS
Our previous studies were demonstrated that the proliferation of ECs started at 1.5-day of high-fl ow and density of ECs was peaked at 3.0-day of highfl ow, when high-fl ow was loaded in the rabbit common carotid arteries (CCAs) using AVF method (5, 9) . Following this timetable, we planned high-fl ow loading for 1.5 days in the rabbit CCAs using AVF method. Then, we made flow normalization, flow removal, or in vitro culture of ECs and observed ECs for additional 1.5 days (at 3.0 days after creation of AVF) (Fig. 1) .
We used adult Japanese white rabbits (weighing 3-4 kg; n = 39). All animal procedures were approved by the Animal Research Committee, Akita University School of Medicine and performed in compliance with the Guidelines for Animal Experimentation of Akita University School of Medicine.
1) High-fl ow experiments
1.1. Creation of high-fl ow Animals were sedated with xylazine (4 mg/kg, intra- the pulse labeling time point, even after their mitotic division. Ten animals were euthanized at 1.5-day of AVF. Five animals were euthanized after 1.5 days tracking, namely at 3.0-day of AVF.
Terminal procedure
Before animals were euthanized, they were anesthetized similarly as described above (1.1.). After laparotomy, a catheter was inserted into the abdominal aorta at the portion of 2 to 3 cm distal to the renal arteries (1, 5, 8, 10) . Animals were then euthanized by injection of an overdose of pentobarbital solution (100 mg/kg) through the aortic catheter. All animals were pressure perfusion fi xed with 4% paraformaldehyde solution in 0.1 M phosphate buffer (pH 7.4). Mean blood fl ow measurement was not performed at euthanasia, because the CCAs tend to cause spasm by the attachment of a fl ow meter probe and as a consequence en face microscopic observation of ECs becomes hard.
En face observation of ECs with a laser scanning confocal microscopy (LSCM)
The segments of the left CCAs, 0.5 cm in length, proximal to the thyroid artery branch were used for observation of ECs by a LSCM as previously described (1, 8, 10) . After perfusion fi xation, samples were frozen in PBS. After dissolving, they were incubated with 0.5% Triton X 100 in 2 N HCl for 30 min followed by washing with PBS and were blocked with goat serum (1 : 100) for 30 min at room temperature. Samples were then incubated with anti-BrdU mouse monoclonal antibody (Becton-Dickinson Immunocytometry Systems, San Jose, CA, USA) at 1 : 50 dilution in 0.1% BSA in PBS, which was detected with a fl uorescein isothiocynateconjugated anti-mouse IgG (Becton-Dickinson Immunocytometry Systems). The samples were then stained with propidium iodide for counter staining of all nuclei. After they were opened longitudinally, the whole wall of opened segments was dipped in 1, 4 Diazabicyclo [2.2.2.] -octane (Dako Cytomation Inc., Carpinteria, CA, USA) glycerin solution (50%) and mounted on the glass slide with the lumen side facing up, and covered with a cover slip for observation under LSCMs. The specimens were observed en face under LSCMs (LSM 410 and LSM 510 META, Carl Zeiss Co., Ltd., Oberkochen, Germany) using a HeNe laser (488 nm) and an Argon laser (530 nm). The HeNe laser stimulates fl uorescein isothiocynate to emit green fl uorescence, and the Argon laser stimulates propidium iodide for counter staining of all nuclei, emitting red fluorescence.
ECs, which were not labeled with BrdU, were observed in red. ECs, which were labeled with BrdU, were observed in yellow to green, because they were emitted green and red fl uorescence together. EC density and numbers of BrdU-labeled ECs were counted in each 320 × 320 μm image, and mean of fi ve images were calculated.
2) Normalization of high-fl ow by AVF closure At 1.5-day of AVF, animals (n = 4) were anesthetized similarly as described above (1.1.). Closure of AVF was performed by closing anastomosis with clipping. BrdU was administrated 1 h before the clipping as described above (1.2.). Normalization of blood fl ow of the left CCA was confi rmed by using an electromagnetic flow meter. After 1.5 days of high-fl ow normalization, animals were euthanized as described above (1.3.). The segments of the left CCAs, 0.5 cm in length, proximal to the thyroid artery branch were used for en face observation of ECs by LSCMs as described above (1.4.). Mean blood fl ow measurement was not performed at euthanasia, because the CCAs tend to cause spasm by the attachment of a fl ow meter probe and as a consequence en face microscopic observation of ECs becomes hard.
3) Removal of high-fl ow by ex vivo organ culture At 1.5-day of AVF, animals (n = 4) were anesthetized similarly as described above (1.1.) and the segments of the left CCAs, 0.5 cm in length, proximal to the thyroid artery branch were resected after BrdU administration 1 h before resection as described above (1.2.). Mean blood fl ow measurement was not performed at resection, because the CCAs tend to cause spasm by the attachment of a fl ow meter probe and as a consequence the resected CCAs contracted severely. The resected CCAs were cultured ex vivo without opening the lumen in EBM-2 (Cambrex BioScience Wakersvill Inc., Walkersville, MD, USA), including glutamine, penicillin, streptomycin, 2.0% fetal bovine serum at 37°C in an atmosphere of 5% CO 2 for 1.5 days. Samples from animals without an AVF operation and were cultured ex vivo for 1.5 days after BrdU administration 1 h before resection, and used as ex vivo control (n = 4). The resected CCAs including controls were fi xed with 4% paraformaldehyde for 40 min after 1.5 days of ex vivo culture. They were processed for en face observation of ECs by LSCMs as described above (1.4.).
4) In vitro culture of ECs
At 1.5-day of AVF, animals (n = 4) were anesthetized similarly as described above (1.1.) and the segments of the left CCAs, 2.0 cm in length, were resected after BrdU administration 1 h before resection as described above (1.2.). Mean blood flow measurement was not performed at resection, because the CCAs tend to cause spasm by the attachment of a fl ow meter probe and as a consequence the resected CCAs contracted severely. The lumens of the resected CCAs were flushed by medium, EBM-2, including gentamycin and fungizone, to wash out the blood. Then, the vessels were treated with collagenase and incubated at 37°C in an atmosphere of 5% CO 2 for 30 min. After 30 min, the cells were isolated by centrifugation of collected fl ush medium at 800 rpm for 5 min. Isolated cells obtained by this procedure were in the range of 0.5 − 1.5 × 10 4 cells in each resected CCA. Some cells were clustered in various sizes consisting of up to about 60 cells.
The isolated cells were plated on type I collagencoated glass cover slips (12 mm in diameter; Asahi Techno Glass, Chiba, Japan) and cultured in EBM-2 supplemented with glutamine, penicillin, streptomycin, 2.0% fetal bovine serum at 37°C in an atmosphere of 5% CO 2 . The culture was maintained for 1.5 days (for observation of BrdU-labeled ECs) and 3.5 days (for evaluation of cell growth). The attached cells were observed with phase-contrast microscopy in every 12 h. In all the wells, many cells were attached as early as 0.5-day of cell culture. To evaluate cell growth, the numbers of cells were counted in three clusters in each animal. The individual clusters were observed in every 12 h and the growth ratio of each cluster (cell numbers of a cluster at each time point/cell numbers of the same cluster at 0.5-day of cell culture) was estimated. Each cell cluster can be followed till 3.5-day of cell culture based on the characteristic shape. To characterize the cultured cells, immunofl uorescent stainings by CD31 and α smooth muscle actin were performed after the cells were fi xed with 4% paraformaldehyde for 40 min. BrdU-labeled ECs were detected immunohistochemically by anti-BrdU mouse monoclonal antibody at 1.5-day of culture. Numbers of BrdU-labeled ECs were counted in fi ve clusters, and mean of fi ve clusters were calculated. Samples from animals without an AVF operation (n = 4) were cultured in vitro for 1.5 days after BrdU administration, and were used as control.
RESULTS

Blood fl ow
Mean blood fl ow of the left CCA prior AVF creation was 15-20 ml/min and it increased 40-60 ml/ min immediately subsequent to AVF creation. These results was similar to that measured in our previous study (5) . In normalization experiments, mean blood fl ow was 80-100 ml/min prior AVF closure at 1.5-day of AVF and 15-20 ml/min immediately subsequent to AVF closure, showing high-flow normalization procedure was succeeded.
High-fl ow experiments
At 1.5-day of high-fl ow, BrdU pulse-labeled ECs, which correspond to S-phase ECs, were often observed (157 ± 107 cells/mm 2 ; 6.3 ± 4.3%, Fig. 2B ), while in the usual physiologic state, very few BrdU pulse-labeled ECs (2 ± 1 cells/mm 2 ; 0.08 ± 0.07%, Fig. 2A ) were observed in the CCA. BrdU-labeled ECs appeared in 3214 ± 367 cells/mm 2 (67.7 ± 4.7%), when pulse-labeled animals at 1.5-day of AVF were tracked for 1.5 days (3.0-day of AVF) ( Table 1 and Fig. 2C ).
Normalization of high-fl ow
BrdU-labeled ECs appeared in 856 ± 264 cells/ mm 2 (28.3 ± 7.1%), when pulse-labeled animals at 1.5-day of AVF were kept in a situation of fl ow normalization for additional 1.5 days (Table 1 and Fig.  2D ).
Removal of high-fl ow by ex vivo organ culture
In animals, which were removed of high-fl ow after high-fl ow loading for 1.5 days and were maintained ex vivo for 1.5 days, ECs had tendency to be abraded from the internal elastic layer, and BrdU-labeled ECs were counted in the portion where ECs had not been abraded. BrdU-labeled ECs appeared in 1118 ± 265 cells/mm 2 (35.4 ± 8.4%) ( Table 1 and Fig. 2E ). In animals without AVF, which were maintained ex vivo for 1.5 days, a few BrdU-labeled ECs were observed (25 ± 21 cells/mm 2 ; 0.9 ± 0.8%, Fig. 2F ).
Isolation and culture in vitro
Isolated cells from the high-fl ow loading animals for 1.5 days were round in shape and about twice as large as erythrocyte. They sometimes gathered together forming clusters consisting of up to 60 cells. These cells were attached to type I collagen-coated cover slips within 0.5 days. At 0.5-day of culture, one growth layer of spindle-shaped cells grew radi-ally from almost all the clusters (Fig. 3A) . Single cell or twin cells occasionally appeared. At 1.0-day of culture, 2 to 3 growth layers of spindle-shaped cells appeared in almost all the clusters (Fig. 3B ). There were no single cells, while twin cells or quadruplet cells clusters appeared. At 1.5-day of culture, spindle-shaped cells formed more than 3 growth layers to become slightly polygonal in the outermost growth layer (Fig. 3C) . At 2.0-day of culture, spindle-shaped cells formed more than 4 growth layers and cells in the outer growth layer became polygonal. At 2.5-day of culture, more than 5 growth layers of cells grew (Fig. 3D) . At 3.5-day of culture, number of cells was almost as many as that of 2.5-day of culture (Fig. 3E) . Cells in the outermost growth layer became much polygonal and showed cobblestone appearance, however, cells in the innermost growth layer were still spindleshaped. Number of cells in clusters increased from 0.5-day to 2.0-day of culture nearly to 14-fold as much as those of cells at 0.5-day of culture (Fig. 4) . After 2.5-day of culture, number of cells in clusters remained almost unchanged.
Immunohistochemistry revealed that almost all the cultured cells were ECs expressing CD31 (Fig.  5B) and not expressing α-smooth muscle actin. At 1.5-day of culture, BrdU-labeled ECs appeared in 16.7 ± 9.6% (Table 1 and Fig. 5C ). Isolated cells from normal-fl ow animals were in the range of 0.2 − 0.3 × 10 4 cells in each resected CCA. Isolated cells were single cell, twin cells, or forming clusters up to 10 cells. They were far fewer and smaller than those from the high-flow loading animals. Their cluster sizes and densities were almost unchanged, almost all of which were proved CD31 positive. There were no BrdU-labeled cells at 1.5-day of culture (Table 1) . At 2.0-day of culture, we could not recognize these clusters of ECs.
DISCUSSION
Our previous study revealed that high-fl ow in blood vessels drove EC proliferation, where ECs started to enter the S-phase at 1.5-day after high-fl ow loading and progenies of the S-phase ECs at 1.5-day increased more than 10-fold at 3.0-day (9). We suggested that the S-phase ECs at 1.5-day proliferated continuously during additional 1.5 days.
However, it is not certain whether continuous high-fl ow is necessary during the whole period of the proliferation of ECs or only transient high-fl ow is required at the beginning of the proliferation, because during the period of the latter 1.5 days (from 1.5-day to 3.0-day of AVF) high-fl ow was kept high so far we have observed (5, 9) . This study aims to investigate the proliferation of ECs, which have once been stimulated by high-fl ow loading, in a situation without the infl uence of high-fl ow.
In the present experiments, we could reconfi rm that there was an increase of S-phase ECs, that is BrdU pulse-labeled ECs, at 1.5-day of AVF and a remarkable increase in the number of BrdU-labeled ECs at 3.0-day of AVF, which had been pulse-labeled at 1.5-day. If all the BrdU-labeled ECs at 3.0-day of AVF were the progenies of the BrdU pulse-labeled ECs (S-phase ECs) at 1.5-day, the S-phase ECs would increase more than 20-fold dur- ing this short period of 1.5 days. Although it is also considered that during 1.5-day to 3.0-day of AVF some BrdU pulse-labeled cells at 1.5-day of AVF in other parts of the body may migrate to become ECs, these S-phase ECs would divide several times during this short period of 1.5 days.
In normalization of high-fl ow experiments, BrdUlabeled ECs were 5.2-fold more than S-phase ECs of 1.5-day. They were one forth less than those in animals, which were pulse-labeled at 1.5-day of AVF and tracked until 3.0-day of AVF. If BrdU pulse-labeled ECs at 1.5-day divided twice, BrdUlabeled ECs would be 4-fold more than those of 1.5-day. Therefore it is probable that BrdU-labeled ECs, S-phase ECs at 1.5-day of AVF, would divide more than once, although it is also considered that during 1.5-day to 3.0-day of fl ow-normalization period some BrdU pulse-labeled cells at 1.5-day of AVF in other parts of the body may migrate to become ECs.
In removal of high-fl ow by ex vivo experiments, BrdU-labeled ECs were about 7.1-fold more than those in animals, which were pulse-labeled at 1.5-day of AVF. They were one third as many as those in animals, which were pulse-labeled at 1.5-day of AVF and tracked until 3.0-day of AVF. However, in these experiments, because there appears no migration after removal, all the BrdU-labeled ECs 1.5 days after removal should be the progenies of the BrdU pulse-labeled ECs at 1.5-day of AVF. Therefore BrdU pulse-labeled ECs at 1.5-day of AVF would divide twice to three times during 1.5 days of ex vivo. From these in vivo and ex vivo experiments, we suspect that S-phase ECs at 1.5-day increase more than twice of mitotic divisions even though high-fl ow is normalized or fl ow is removal, while S-phase ECs at 1.5-day of AVF increased remarkably much more when fl ow is kept high.
However, these in vivo and ex vivo experiments lacked individual cell follow-up. That is to say that, in these experiments, relationship of BrdU pulse-labeled ECs at 1.5-day of AVF and tracked BrdU-labeled ECs after 1.5 days of high-flow or flow normalization or removal was only speculated, be-cause these experiments used different animals at 1.5-day of AVF and after 1.5-day of fl ow alteration or removal.
To ensure the relationship of S-phase ECs at 1.5-day of AVF, S-phase ECs at 1.5-day of AVF after additional 1.5 days of AVF and those after 1.5-day of fl ow alteration or removal, we tried in vitro study. It revealed rapid increase (14-fold) of ECs from 0.5-day to 2.0-day of culture. After 2.5-day of culture, number of ECs remained unchanged. Therefore we consider that in culture from 1.5 days high-fl ow animals cultured ECs transiently proliferated by 3-to 4-divisions. Furthermore in the cultured proliferating ECs there were BrdU-labeled ECs at 1.5-day of culture, which were the progenies of the BrdU pulse-labeled ECs at 1.5-day of AVF, although their percentage was only 16%.
These results suggest that ECs, which had once been stimulated by high-flow loading, transiently proliferated even after normalization of high-fl ow or removal of fl ow. We assume two possibilities for the origin of these proliferating ECs. First possibility is that in situ ECs may gain character promised to proliferate during high-fl ow loading for 1.5 days. Second possibility is that the appearance of de novo ECs, which are promised to proliferate. In the present investigation, both possibilities are considered. Although further investigations are needed to confi rm the origin of these proliferating cells, it seems that S-phase ECs at 1.5-day of high-fl ow are programmed to transiently proliferate through 3-4 mitotic divisions.
In conclusion, our study found that normalization of fl ow or removal of fl ow could not stop high-fl ow induced endothelial proliferation. ECs could proliferate in spite of normalization or removal of highflow. These results suggest that specific ECs are involved in early stage of arterial remodeling and are promised to promote a proliferation program at the moment of beginning to proliferate.
